APP and early-onset autosomal dominant Alzheimer disease: In double transgenic AD mouse (AβPP/PS1), NBP reduced Aβ production [46] while, in triple transgenic mouse (3xTg-AD), NBP intervened with APP processing and alleviated oxidative stress, implicating its potential use in Alzheimer's disease and other forms of dementia [47].